These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26279981)

  • 1. Prion-induced neurotoxicity: Possible role for cell cycle activity and DNA damage response.
    Bujdoso R; Landgraf M; Jackson WS; Thackray AM
    World J Virol; 2015 Aug; 4(3):188-97. PubMed ID: 26279981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional signature of prion-induced neurotoxicity in a Drosophila model of transmissible mammalian prion disease.
    Thackray AM; Lam B; Shahira Binti Ab Razak A; Yeo G; Bujdoso R
    Biochem J; 2020 Feb; 477(4):833-852. PubMed ID: 32108870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion-induced and spontaneous formation of transmissible toxicity in PrP transgenic Drosophila.
    Thackray AM; Di Y; Zhang C; Wolf H; Pradl L; Vorberg I; Andréoletti O; Bujdoso R
    Biochem J; 2014 Oct; 463(1):31-40. PubMed ID: 25000212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic human prion disease modelled in PrP transgenic
    Thackray AM; Cardova A; Wolf H; Pradl L; Vorberg I; Jackson WS; Bujdoso R
    Biochem J; 2017 Sep; 474(19):3253-3267. PubMed ID: 28814578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic PrP can participate in prion-mediated toxicity.
    Thackray AM; Zhang C; Arndt T; Bujdoso R
    J Virol; 2014 Jul; 88(14):8129-38. PubMed ID: 24807727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion-induced toxicity in PrP transgenic Drosophila.
    Thackray AM; Muhammad F; Zhang C; Denyer M; Spiropoulos J; Crowther DC; Bujdoso R
    Exp Mol Pathol; 2012 Apr; 92(2):194-201. PubMed ID: 22314254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
    Sarnataro D
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioassay of prion-infected blood plasma in PrP transgenic Drosophila.
    Thackray AM; Andreoletti O; Bujdoso R
    Biochem J; 2016 Dec; 473(23):4399-4412. PubMed ID: 27733649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Generation of New PrPSc on Blood Vessels after Brain Microinjection of Scrapie in Mice.
    Chesebro B; Striebel J; Rangel A; Phillips K; Hughson A; Caughey B; Race B
    mBio; 2015 Sep; 6(5):e01419-15. PubMed ID: 26396245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models for prion-like diseases.
    Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
    Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Prion Amplification Methodology for Inhibitor Screening.
    Vieira TCRG; Silva JL
    Methods Mol Biol; 2019; 1873():305-316. PubMed ID: 30341619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions.
    Poggiolini I; Saverioni D; Parchi P
    Int J Cell Biol; 2013; 2013():910314. PubMed ID: 24454379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting prion-like protein spreading in neurodegenerative diseases.
    Zhang Z; Nie S; Chen L
    Neural Regen Res; 2018 Nov; 13(11):1875-1878. PubMed ID: 30233055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile Acids Reduce Prion Conversion, Reduce Neuronal Loss, and Prolong Male Survival in Models of Prion Disease.
    Cortez LM; Campeau J; Norman G; Kalayil M; Van der Merwe J; McKenzie D; Sim VL
    J Virol; 2015 Aug; 89(15):7660-72. PubMed ID: 25972546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
    Eraña H; Venegas V; Moreno J; Castilla J
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review: membrane-associated misfolded protein propagation in natural transmissible spongiform encephalopathies (TSEs), synthetic prion diseases and Alzheimer's disease.
    Jeffrey M
    Neuropathol Appl Neurobiol; 2013 Apr; 39(3):196-216. PubMed ID: 23171056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POSCAbilities: The Application of the Prion Organotypic Slice Culture Assay to Neurodegenerative Disease Research.
    Pineau H; Sim V
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32698402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.